Nano Well-being Health issues voluntary recall of Super Arthgold due to undeclared drug ingredients

Nano Well-being Health has issued voluntary nationwide recall of two lots of Super Arthgold, 500 mg capsules to the consumer level. The recall was initiated after the FDA has found the product to contain chlorzoxazone, diclofenac and indomethacin, making it an unapproved new drug. Till date, no injuries or illness have been reported.

The company has recalled L1P1-6100/Expiration date June 25, 2016 and lot L1P2-6000/Expiration date September 16, 2016 of Super Arthgold. The product was used as a dietary supplement for joint pain and arthritis and is packaged in bottles of 120 capsules. The FDA states that the use of this product has a reasonable probability of resulting in fatal adverse events in consumers with underlying illnesses. These illnesses include allergies to the hidden ingredients, cardiac, gastrointestinal, hepatic and renal conditions as well as anyone who has recently undergone cardiac bypass graft surgery.

The product contains Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) that may cause adverse reactions which include but are not limited to myocardial infarction, stroke, congestive heart failure, renal toxicity, and bleeding, ulceration, or perforation of the stomach or intestines. The company is notifying its distributors and customers regarding the recall of the products.